Pro-Dex (co) Accounts Payable

The latest accounts payable for PDEX is $5.2M as of March 2026. That compares with $6M in the prior-year period — down 12.0% year over year. Investors often review this figure alongside Pro-Dex (co)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PDEX's accounts payable moved from $6M to $5.2M — a 12.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pro-Dex (co)'s operating scale or balance-sheet position.

A accounts payable figure of $5.2M for PDEX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PDEX's accounts payable ($5.2M), review year-over-year change from $6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pro-Dex (co)'s accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.